NEW YORK (Reuters) - A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S.

I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Click here to ...

Jefferies analyst Akash Tewari maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of ...

Biotech-stock investing has one tough test for success - and it's about to get easier ...

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim ...

Amid a solid earnings picture for the third quarter, many US-listed companies are beating estimates. Combining the results of ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

The S&P 500 fell 2% in the past week, erasing more than half its gains from a post-election surge fueled in part by optimism ...

(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...